Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
The AMYPAD project holds its final General Assembly meeting in Amsterdam
The AMYPAD project holds its final General Assembly meeting in Amsterdam 22 Sep 2022 More than 80 delegates from the AMYPAD consortium came together in Amsterdam.....
Welcome to the 22nd issue of the AMYPAD Newsletter
Welcome to the 22nd issue of the AMYPAD Newsletter 07 Sep 2022 We are back at work again after summer holidays and it's hard to believe that our AMYPAD consortium is now in its last month......
Interview with Valentina Garibotto
Interview with Valentina Garibotto 29 Aug 2022 I am a nuclear medicine specialist and I have a long standing collaboration with Prof. Giovanni Frisoni......
Recruitment status (as 30 April 2022)
Recruitment status (as 30 April 2022)